In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease

Standard

In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease. / Huddleston, Daniel E; Langley, Jason; Sedlacik, Jan; Boelmans, Kai; Factor, Stewart A; Hu, Xiaoping P.

in: HUM BRAIN MAPP, Jahrgang 38, Nr. 5, 05.2017, S. 2627-2634.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Huddleston, DE, Langley, J, Sedlacik, J, Boelmans, K, Factor, SA & Hu, XP 2017, 'In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease', HUM BRAIN MAPP, Jg. 38, Nr. 5, S. 2627-2634. https://doi.org/10.1002/hbm.23547

APA

Huddleston, D. E., Langley, J., Sedlacik, J., Boelmans, K., Factor, S. A., & Hu, X. P. (2017). In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease. HUM BRAIN MAPP, 38(5), 2627-2634. https://doi.org/10.1002/hbm.23547

Vancouver

Huddleston DE, Langley J, Sedlacik J, Boelmans K, Factor SA, Hu XP. In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease. HUM BRAIN MAPP. 2017 Mai;38(5):2627-2634. https://doi.org/10.1002/hbm.23547

Bibtex

@article{4fca718e01064eb492fb3147afba4d7b,
title = "In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease",
abstract = "The objective of this study was to measure neuromelanin-sensitive MRI contrast changes in the lateral-ventral tier of substantia nigra pars compacta in Parkinson's disease (PD). Histopathological studies of PD have demonstrated both massive loss of melanized dopamine neurons and iron accumulation in the substantia nigra pars compacta. Neurodegeneration is most profound in the lateral-ventral tier of this structure. We have previously shown in both healthy controls and individuals with PD that neuromelanin-sensitive MRI and iron-sensitive MRI contrast regions in substantia nigra overlap. This overlap region is located in the lateral-ventral tier. Exploiting this area of contrast overlap for region of interest selection, we developed a semi-automated image processing approach to characterize the lateral-ventral tier in MRI data. Here we apply this approach to measure magnetization transfer contrast, which corresponds to local neuromelanin density, in both the lateral-ventral tier and the entire pars compacta in 22 PD patients and 19 controls. Significant contrast reductions were seen in PD in both the entire pars compacta (P = 0.009) and in its lateral-ventral tier (P = 0.0002); in PD contrast was significantly lower in the lateral-ventral tier than in the entire pars compacta (P = 0.0008). These findings are the first in vivo evidence of the selective vulnerability of this nigral subregion in PD, and this approach may be developed for high impact biomarker applications. Hum Brain Mapp 38:2627-2634, 2017. {\textcopyright} 2017 Wiley Periodicals, Inc.",
keywords = "Journal Article",
author = "Huddleston, {Daniel E} and Jason Langley and Jan Sedlacik and Kai Boelmans and Factor, {Stewart A} and Hu, {Xiaoping P}",
note = "{\textcopyright} 2017 Wiley Periodicals, Inc.",
year = "2017",
month = may,
doi = "10.1002/hbm.23547",
language = "English",
volume = "38",
pages = "2627--2634",
journal = "HUM BRAIN MAPP",
issn = "1065-9471",
publisher = "Wiley-Liss Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease

AU - Huddleston, Daniel E

AU - Langley, Jason

AU - Sedlacik, Jan

AU - Boelmans, Kai

AU - Factor, Stewart A

AU - Hu, Xiaoping P

N1 - © 2017 Wiley Periodicals, Inc.

PY - 2017/5

Y1 - 2017/5

N2 - The objective of this study was to measure neuromelanin-sensitive MRI contrast changes in the lateral-ventral tier of substantia nigra pars compacta in Parkinson's disease (PD). Histopathological studies of PD have demonstrated both massive loss of melanized dopamine neurons and iron accumulation in the substantia nigra pars compacta. Neurodegeneration is most profound in the lateral-ventral tier of this structure. We have previously shown in both healthy controls and individuals with PD that neuromelanin-sensitive MRI and iron-sensitive MRI contrast regions in substantia nigra overlap. This overlap region is located in the lateral-ventral tier. Exploiting this area of contrast overlap for region of interest selection, we developed a semi-automated image processing approach to characterize the lateral-ventral tier in MRI data. Here we apply this approach to measure magnetization transfer contrast, which corresponds to local neuromelanin density, in both the lateral-ventral tier and the entire pars compacta in 22 PD patients and 19 controls. Significant contrast reductions were seen in PD in both the entire pars compacta (P = 0.009) and in its lateral-ventral tier (P = 0.0002); in PD contrast was significantly lower in the lateral-ventral tier than in the entire pars compacta (P = 0.0008). These findings are the first in vivo evidence of the selective vulnerability of this nigral subregion in PD, and this approach may be developed for high impact biomarker applications. Hum Brain Mapp 38:2627-2634, 2017. © 2017 Wiley Periodicals, Inc.

AB - The objective of this study was to measure neuromelanin-sensitive MRI contrast changes in the lateral-ventral tier of substantia nigra pars compacta in Parkinson's disease (PD). Histopathological studies of PD have demonstrated both massive loss of melanized dopamine neurons and iron accumulation in the substantia nigra pars compacta. Neurodegeneration is most profound in the lateral-ventral tier of this structure. We have previously shown in both healthy controls and individuals with PD that neuromelanin-sensitive MRI and iron-sensitive MRI contrast regions in substantia nigra overlap. This overlap region is located in the lateral-ventral tier. Exploiting this area of contrast overlap for region of interest selection, we developed a semi-automated image processing approach to characterize the lateral-ventral tier in MRI data. Here we apply this approach to measure magnetization transfer contrast, which corresponds to local neuromelanin density, in both the lateral-ventral tier and the entire pars compacta in 22 PD patients and 19 controls. Significant contrast reductions were seen in PD in both the entire pars compacta (P = 0.009) and in its lateral-ventral tier (P = 0.0002); in PD contrast was significantly lower in the lateral-ventral tier than in the entire pars compacta (P = 0.0008). These findings are the first in vivo evidence of the selective vulnerability of this nigral subregion in PD, and this approach may be developed for high impact biomarker applications. Hum Brain Mapp 38:2627-2634, 2017. © 2017 Wiley Periodicals, Inc.

KW - Journal Article

U2 - 10.1002/hbm.23547

DO - 10.1002/hbm.23547

M3 - SCORING: Journal article

C2 - 28240402

VL - 38

SP - 2627

EP - 2634

JO - HUM BRAIN MAPP

JF - HUM BRAIN MAPP

SN - 1065-9471

IS - 5

ER -